Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infected”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01908660
What this trial is testing

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

Who this might be right for
Human Immunodeficiency VirusHepatitis B, ChronicHepatitis C, Chronic
Valme University Hospital 192
Early research (Phase 1)Study completedNCT02652546
What this trial is testing

CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)

Who this might be right for
HIV, Inflammation
National Institute of Allergy and Infectious Diseases (NIAID) 38
Not applicableUnknownNCT05372510
What this trial is testing

Feasibility of Identifying, Enrolling and Following Acute and Early HIV-1 Infected Individuals.

Who this might be right for
Acute Human Immunodeficiency Virus Type I Infection
MRC/UVRI and LSHTM Uganda Research Unit 100
Early research (Phase 1)Study completedNCT00002383
What this trial is testing

A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 80
Large-scale testing (Phase 3)Study completedNCT00670839
What this trial is testing

Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)

Who this might be right for
Hepatitis BHIV Infection
ANRS, Emerging Infectious Diseases 178
Not applicableEnded earlyNCT02839603
What this trial is testing

Asymptomatic Leishmania Infection in HIV Patients

Who this might be right for
Visceral Leishmaniasis
Institute of Tropical Medicine, Belgium 540
Early research (Phase 1)Study completedNCT00000777
What this trial is testing

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)

Who this might be right for
HIV InfectionsPregnancyHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT01047995
What this trial is testing

Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects

Who this might be right for
HIV Infections
St Stephens Aids Trust 26
Testing effectiveness (Phase 2)Study completedNCT01656070
What this trial is testing

Vitamin D Supplementation in HIV-infected Youth

Who this might be right for
HIV DiseaseVitamin D DeficiencyHypovitaminosis D+1 more
University of Milan 50
Not applicableStudy completedNCT01201083
What this trial is testing

Study of Recently HIV Infected Men and Transmission Behaviors

Who this might be right for
HIV
University of California, Los Angeles 600
Not applicableStudy completedNCT02497456
What this trial is testing

The Effectiveness of a Counselling Intervention on the Uptake of HIV Care Services Among HIV Infected Patients in Uganda

Who this might be right for
HIV
MRC/UVRI and LSHTM Uganda Research Unit 338
Not applicableStudy completedNCT00339612
What this trial is testing

NISDI Pediatric Latin American Countries Epidemiologic Study (PLACES): A Prospective Observational Study of HIV-Infected Children at Clinical Sites in Latin American Countries

Who this might be right for
HIV
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2,129
Not applicableStudy completedNCT02578654
What this trial is testing

Interventions to Improve HIV Care Engagement After Hospital Discharge

Who this might be right for
HIV/AIDS
Thammasat University 240
Large-scale testing (Phase 3)Study completedNCT00143702
What this trial is testing

D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)

Who this might be right for
Acidosis, Lactic
University of British Columbia 80
Early research (Phase 1)Study completedNCT00000901
What this trial is testing

Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Post-approval studies (Phase 4)Study completedNCT01458977
What this trial is testing

Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors

Who this might be right for
HIVDyslipidemia
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 48
Not applicableStudy completedNCT00979420
What this trial is testing

Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune

Who this might be right for
HIV Infections
Boehringer Ingelheim
Large-scale testing (Phase 3)Study completedNCT03921424
What this trial is testing

Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 407
Testing effectiveness (Phase 2)Study completedNCT00002324
What this trial is testing

The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease

Who this might be right for
HIV Infections
Boehringer Ingelheim 250
Large-scale testing (Phase 3)Study completedNCT02345226
What this trial is testing

Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 881
Next Page